Ketamine and Spravato Treatment in Pennsylvania

Independent, sourced information for people in Philadelphia, Pittsburgh, Harrisburg and across Pennsylvania — written for patients and families, and dated so you can see how current it is.

What it costs in Pennsylvania Does Pennsylvania Medical Assistance cover it?

This is an independent information resource. We are not a clinic, not a treatment provider, and not a REMS-certified facility. We cannot book appointments or make referrals. No clinic pays to be listed here.

Pennsylvania at a glance

Clinicians listed in Pennsylvania: 40 Registered clinicians whose federal NPI record carries a relevant specialty. This is the exact number on our list — not an estimate, and not a claim that all of them offer ketamine. Last checked 2026-05-30. See the list and its limits.
Metro areas covered: 10 Philadelphia, Pittsburgh, Harrisburg, Allentown, Bethlehem, Scranton, Erie, Lancaster, York, Reading.
Typical IV session, paying cash: $350–$500 18 Jul 2026 · Published Pennsylvania clinic price lists (source 4, opens in a new tab)
Pennsylvania prescription monitoring programme: PA PDMP 18 Jul 2026 · Pennsylvania Department of Health (source 3, opens in a new tab)

What will this cost me in Pennsylvania?

Answer a few questions and we will show a range — or tell you plainly when we cannot give you a number worth having. Nothing you choose is sent anywhere, and there is nothing to sign up for.

$350 – $500 per IV session, paying cash The estimator needs JavaScript to respond to your answers. Without it, here is the figure most people arrive looking for: a single IV ketamine session in Pennsylvania typically costs this much, and a first course is usually six sessions. Spravato is billed differently and depends almost entirely on your insurance — our insurance page covers that without needing JavaScript. This is an estimate, not a quote. The clinic sets the price.

Based on published pricing and coverage rules as of 2019-03-05. Sources for every figure this tool can show:

Only esketamine (Spravato) is FDA-approved to treat depression. Racemic ketamine given by IV, injection, or under the tongue has no FDA approval for any psychiatric condition and is used off-label — that is, an approved drug used for an unapproved purpose. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 1, opens in a new tab)

Under Original Medicare Part B in 2026 you pay a $283 yearly deductible first, and after that you generally pay 20% of the Medicare-approved amount for covered services. as of 1 Jan 2026 · Centers for Medicare and Medicaid Services (source 2, opens in a new tab)Deductible and premium amounts are set annually and change each January.

Pennsylvania Medical Assistance covers Spravato, but lists it as a non-preferred medicine on the statewide preferred drug list, which means prior approval is required before your plan will pay. The same rules apply whether you are in fee-for-service or a managed care plan. as of 1 Jan 2026 · Pennsylvania Department of Human Services (source 3, opens in a new tab)

In Pennsylvania an intramuscular ketamine injection costs around $400 at clinics that provide the injection alone, rising to roughly $650 to $1,400 a session at practices where a therapist stays with you for the whole two to three hours. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 5, opens in a new tab)The wide spread is real: it reflects whether you are paying for an injection or for several hours of a clinician's time.

Pennsylvania clinics that publish their prices charge roughly $350 to $500 for a single IV ketamine infusion, with a six-session starting course commonly priced at around $2,100 to $2,500. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 6, opens in a new tab)Based on five Pennsylvania clinics that publish prices. Most do not, and the clinic sets the price — treat this as a guide to what a reasonable answer sounds like, not as a quote.

Sublingual ketamine lozenges themselves are inexpensive in Pennsylvania, at roughly $75 to $200 for a prescription. Supervised lozenge sessions are billed separately by clinician time, at roughly $500 to $1,250 a session. as of 18 Jul 2026 · Published Pennsylvania clinic price lists (source 7, opens in a new tab)These are two different things and quotes often conflate them. Ask whether a price covers the medicine, the supervised session, or both.

Best available information: No Pennsylvania clinic we could find publishes a self-pay price for Spravato. National figures suggest roughly $850 to $1,600 a session covering both the medicine and the required two-hour monitoring, but we have no Pennsylvania figure we would stand behind. as of 5 May 2026 · HealingMaps (source 8, opens in a new tab)This is a national figure from one secondary directory, not a Pennsylvania price. Our estimator does not produce a self-pay Spravato number from it, because it is not good enough evidence to build a figure on.

The FDA approved Spravato (esketamine) nasal spray on 5 March 2019, for use with an oral antidepressant, for adults with treatment-resistant depression. as of 5 Mar 2019 · U.S. Food and Drug Administration (source 11, opens in a new tab)

Spravato is available only through a restricted safety programme called a Risk Evaluation and Mitigation Strategy (REMS), and may only be given in a certified healthcare setting under a provider's direct observation. Patients never take it home. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 14, opens in a new tab)

Best available information: Spravato's list price is not published by the manufacturer or in any free public source. At launch in 2019 the wholesale acquisition cost was around $590 for a 56 mg dose and $885 for an 84 mg dose, and the current list price is very likely higher. as of 5 Mar 2019 · Drugs.com (source 15, opens in a new tab)Wholesale acquisition cost is published only in paywalled pricing compendia. The figures here are seven years old and come from a secondary source, so we do not use them to produce a dollar estimate — the estimator suppresses Spravato cash figures rather than presenting a number this weak.

The Spravato withMe savings programme is not available to anyone using a state or federal government health programme, including Medicare, Medicaid, TRICARE, the Department of Defense, and the Veterans Administration. as of 18 Jul 2026 · Johnson & Johnson (source 16, opens in a new tab)

Through the Spravato withMe savings programme, eligible patients with commercial insurance may pay as little as $10 per treatment for the medicine itself, subject to yearly maximum benefits and quantity limits. as of 18 Jul 2026 · Johnson & Johnson (source 17, opens in a new tab)The programme covers the medicine, not the office visit or the two-hour observation, which is often the larger share of the bill. The official terms state that a yearly maximum applies but do not publish the amount, so we do not either. Terms are set per calendar year.

See the full cost breakdown for Pennsylvania

The three questions people arrive with

What does it cost?

A single IV session in Pennsylvania typically runs $350 to $500, and a first course is usually six sessions. Spravato is different, because it is normally billed through insurance.

See the full cost breakdown

Will insurance pay?

Spravato is generally covered with prior approval, including by Pennsylvania Medical Assistance. IV ketamine is off-label and almost never covered, whoever your insurer is.

See what your coverage means here

Where do I actually go?

We list 40 clinicians registered in Pennsylvania whose specialty is associated with ketamine therapy — and we are clear about what that does and does not tell you.

See the list and its limits

The four ways ketamine is given, compared

Cash costs are Pennsylvania bands and are set by the clinic. Every figure below carries its source and date.
Treatment	FDA status	Where and how long	Typical course	Insurance	Driving	Typical cash cost
IV ketamine infusion	Not FDA-approved for depression (off-label)	In a clinic, usually 40–60 minutes plus recovery	Typically six sessions over two to three weeks	Almost never covered	You will need someone to drive you home	$350–$500
Spravato (esketamine)	FDA-approved for treatment-resistant depression	Self-administered nasal spray in a certified clinic, with two hours of monitoring	Twice weekly for four weeks, then less often	Usually billed through insurance, with prior approval	No driving until the next day, after a night of restful sleep	Depends on your coverage
IM injection	Not FDA-approved for depression (off-label)	In a clinic, shorter than an infusion	Varies by clinic	Almost never covered	You will need someone to drive you home	$400–$1,400
Sublingual or lozenge	Not FDA-approved for depression (off-label)	At home, or in a supervised session	Varies widely by programme	Almost never covered	Do not drive after a dose	$500–$1,250

After a Spravato dose you must not drive or operate machinery until the next day, following a restful night's sleep, so you need to arrange a ride home from every session. as of 30 Apr 2025 · U.S. Food and Drug Administration (source 13, opens in a new tab)

Where treatment is available in Pennsylvania

Philadelphia and the Southeast

Pennsylvania's densest concentration of ketamine and Spravato providers, anchored by several academic medical centres, with clinics in Center City and across the Bucks, Montgomery, Delaware and Chester county suburbs.

Philadelphia · Reading

Pittsburgh and the Southwest

The hub for western Pennsylvania, dominated by the UPMC system, serving a wide catchment that reaches the Ohio and West Virginia borders and the thinly served northwestern corner around Erie.

Pittsburgh · Erie

Central Pennsylvania

The Harrisburg, York and Lancaster corridor has a moderate provider base along I-83, and serves a large rural hinterland that has few other options within an hour's drive.

Harrisburg · Lancaster · York

The Northeast and Lehigh Valley

Allentown, Bethlehem, Easton, Scranton and Wilkes-Barre are the main access points for north-eastern Pennsylvania. The Pocono and northern-tier counties often depend on them, or on crossing into New York or New Jersey.

Allentown · Bethlehem · Scranton

If you live near a state line

If you live in the northern tier, the Allegheny highlands, or the coal-region counties, the nearest provider is commonly 60 to 120 minutes each way. Two Pennsylvania rules make that harder than it looks: your first appointment for a controlled substance has to be in person, and every Spravato visit needs a driver because you cannot drive afterwards — twice a week for the first four weeks.

Pennsylvania borders NY, NJ, DE, MD, WV, OH. A clinic across the border may be closer than one in your own state — but check that it is in your insurance network first, and note that a clinician must be licensed where you receive care.

Common questions

Is ketamine treatment legal in Pennsylvania?

In Pennsylvania, medical doctors and osteopathic physicians may prescribe and administer ketamine. A certified registered nurse practitioner may prescribe it — up to a 90-day supply — only under a written collaborative agreement with a physician, and only if it falls within the speciality that agreement covers. Pennsylvania has not adopted full practice authority for nurse practitioners. A physician assistant may prescribe it under a written agreement with a supervising physician. as of 18 Jul 2026 · Pennsylvania Code and Bulletin (source 1, opens in a new tab)The physician assistant rule cited is the State Board of Medicine's. Physician assistants supervised by an osteopathic physician fall under a separate parallel rule that we have not separately checked.

Does Pennsylvania Medical Assistance cover Spravato?

Is Spravato used on its own, or with an antidepressant?

On 17 January 2025 the FDA approved Spravato for treatment-resistant depression in adults either on its own or together with an oral antidepressant, so a companion oral antidepressant is now optional for this use — though it is still permitted. as of 17 Jan 2025 · U.S. Food and Drug Administration (source 3, opens in a new tab)This applies to the treatment-resistant depression indication only. The separate indication for major depressive disorder with acute suicidal ideation still requires an oral antidepressant — see spravato.approval_mdd_si. Widely-cited secondary sources give 21 January 2025; that is the manufacturer's announcement date, not the FDA action date on the approval letter.

Can I drive myself home afterwards?

Why is IV ketamine not covered by my insurance?

Can I get ketamine treatment through telehealth?

Pennsylvania is one of the stricter states here. A State Board of Medicine licensee must carry out an initial in-person physical examination before prescribing a controlled substance, apart from emergencies. A narrow telehealth exception added in December 2024 covers only buprenorphine and methadone in narcotic treatment programmes — it does not cover ketamine. In practice this means your first appointment cannot be done entirely remotely. as of 21 Dec 2024 · Pennsylvania Code and Bulletin (source 4, opens in a new tab)Federal DEA telemedicine flexibilities run separately and expire at the end of 2026, but they do not override a stricter state rule. We have not separately checked the parallel osteopathic board rule.

Can I start ketamine treatment in Pennsylvania entirely by video?

Will my prescriber have to check the state drug monitoring database before prescribing ketamine?

Partly. Because ketamine is neither an opioid nor a benzodiazepine, a Pennsylvania prescriber is not required to check the monitoring system every time they prescribe it — only on the first controlled substance they prescribe you, or if they suspect misuse. Separately, ketamine and Spravato given to you inside a clinic are generally not recorded at all, because the law only covers medicine dispensed for you to take away. as of 18 Jul 2026 · Pennsylvania Department of Health (source 3, opens in a new tab)Take-home sublingual ketamine dispensed by a pharmacy is recorded. In-clinic infusions and Spravato generally are not.